BioCentury | Jul 2, 2020
Emerging Company Profile

Bolt’s myeloid twist on ADCs charged up with $93.5M series C

...and Pfizer Ventures, along with existing investors including Novo Holdings, Vivo Capital, Pivotal bioVenture Partners. Bolt Biotherapeutics Inc.’s...
...that might be better addressed with a different type of innate immune payload. COMPANY PROFILE Bolt Biotherapeutics Inc....
...receptor 2 TLR7 - Toll-like receptor 7 TLR8 - Toll-like receptor 8 Karen Tkach Tuzman, Associate Editor Bolt Biotherapeutics Bolt Biotherapeutics Inc. Toll-like...
BioCentury | May 14, 2020
Management Tracks

Jakob Dupont steps down as CMO of Gossamer; plus Ascendis, Seer, Jazz, Dragonfly and more

...clinical development. She was VP of clinical development at Array BioPharma Inc. Antibody conjugate company Bolt Biotherapeutics Inc....
...role full-time. Robin Sawka, BioCentury Staff Gossamer Bio Inc. Ascendis Pharma A/S Seer Inc. Jazz Pharmaceuticals plc Dragonfly Therapeutics Inc. Caribou Biosciences Inc. Bolt Biotherapeutics Inc. BioDelivery...
BioCentury | Apr 14, 2020
Management Tracks

Kelly joins CytoDyn as CMO amid COVID-19 trials; plus Antengene, Genetron, Bolt, BioSpecifics, CMAB and more

...was the deputy director of FDA’s Division of Molecular Genetics and Pathology. Antibody conjugate company Bolt Biotherapeutics Inc....
...ObsEva’s VP of corporate affairs and finance, will become interim CFO. Robin Sawka, BioCentury Staff CytoDyn Inc. Antengene Corp. Bolt Biotherapeutics Inc. BioSpecifics...
BioCentury | Apr 11, 2020
Management Tracks

Harpal Kumar named president of Grail Europe; plus Notable, Oncoceutics, ReAlta, Parker Institute

...of Genomic Health Inc. (NASDAQ:GHDX). Robin Sawka, BioCentury Staff Grail Inc. Notable Labs Inc. Oncoceutics Inc. Parker Institute for Cancer Immunotherapy Bolt Biotherapeutics Inc. BioSpecifics...
BioCentury | Apr 10, 2020
Management Tracks

Shakeup at Arix; plus Emergent, AlloVir, Asklepios Bio, Morphic, Gritstone and more

...Inc. Dynamk Capital Polyneuron Pharmaceuticals AG Vor Biopharma Inc. Prime Therapeutics LLC Oncoceutics Inc. Exicure Inc. ObsEva S.A. Acacia Pharma Group plc BioSpecifics Technologies Corp. Bolt Biotherapeutics Inc. Notable...
BioCentury | Sep 4, 2019
Company News

Management tracks: PhRMA, Arcus, Beam, Stealth, Bolt, Athenex, Click, Melinta, Kallyope and Genor

...hired Robert Weiskopf as CFO. Weiskopf was CFO of ArQule Inc. (NASDAQ:ARQL). Antibody conjugate company Bolt Biotherapeutics Inc....
...HillHouse Capital affiliated fund. Hongjiang Li, Staff Writer and Mary Romeo, Assistant Editor Arcus Biosciences Inc. Athenex Inc. Beam Therapeutics Bolt Biotherapeutics Inc. Click...
BioCentury | Aug 16, 2019
Finance

Chinese investment in U.S. biotechs to slow further

...biotechs. In February, the firm led the $54 million series B round for immuno-oncology company Bolt Biotherapeutics Inc....
...2020. Companies and Institutions Mentioned Ascletis Pharma Inc. (HKSE:1672), Hangzhou, China BioNTech SE, Mainz, Germany Bolt Biotherapeutics Inc....
BioCentury | Apr 5, 2019
Clinical News

Bolt's immune-stimulating antibody conjugates decrease tumor growth

...models. In a presentation at the American Association for Cancer Research (AACR) meeting in Atlanta, Bolt Biotherapeutics Inc....
...Toll-like receptor 7; TLR8 - Toll-like receptor 8 Mary Romeo, Staff Writer American Association for Cancer Research Bolt Biotherapeutics Inc. Toll-like...
BioCentury | Feb 8, 2019
Financial News

Bolt raises $54M series B

...Autoimmune company Bolt Biotherapeutics Inc. (Redwood City, Calif.) raised $54 million in a series B round led by...
...to convert cold tumors into immunologically hot tumors following systemic administration. Bolt Biotherapeutics Inc., Redwood City, Calif. Shannon Lehnbeuter Bolt Biotherapeutics Inc....
Items per page:
1 - 9 of 9
BioCentury | Jul 2, 2020
Emerging Company Profile

Bolt’s myeloid twist on ADCs charged up with $93.5M series C

...and Pfizer Ventures, along with existing investors including Novo Holdings, Vivo Capital, Pivotal bioVenture Partners. Bolt Biotherapeutics Inc.’s...
...that might be better addressed with a different type of innate immune payload. COMPANY PROFILE Bolt Biotherapeutics Inc....
...receptor 2 TLR7 - Toll-like receptor 7 TLR8 - Toll-like receptor 8 Karen Tkach Tuzman, Associate Editor Bolt Biotherapeutics Bolt Biotherapeutics Inc. Toll-like...
BioCentury | May 14, 2020
Management Tracks

Jakob Dupont steps down as CMO of Gossamer; plus Ascendis, Seer, Jazz, Dragonfly and more

...clinical development. She was VP of clinical development at Array BioPharma Inc. Antibody conjugate company Bolt Biotherapeutics Inc....
...role full-time. Robin Sawka, BioCentury Staff Gossamer Bio Inc. Ascendis Pharma A/S Seer Inc. Jazz Pharmaceuticals plc Dragonfly Therapeutics Inc. Caribou Biosciences Inc. Bolt Biotherapeutics Inc. BioDelivery...
BioCentury | Apr 14, 2020
Management Tracks

Kelly joins CytoDyn as CMO amid COVID-19 trials; plus Antengene, Genetron, Bolt, BioSpecifics, CMAB and more

...was the deputy director of FDA’s Division of Molecular Genetics and Pathology. Antibody conjugate company Bolt Biotherapeutics Inc....
...ObsEva’s VP of corporate affairs and finance, will become interim CFO. Robin Sawka, BioCentury Staff CytoDyn Inc. Antengene Corp. Bolt Biotherapeutics Inc. BioSpecifics...
BioCentury | Apr 11, 2020
Management Tracks

Harpal Kumar named president of Grail Europe; plus Notable, Oncoceutics, ReAlta, Parker Institute

...of Genomic Health Inc. (NASDAQ:GHDX). Robin Sawka, BioCentury Staff Grail Inc. Notable Labs Inc. Oncoceutics Inc. Parker Institute for Cancer Immunotherapy Bolt Biotherapeutics Inc. BioSpecifics...
BioCentury | Apr 10, 2020
Management Tracks

Shakeup at Arix; plus Emergent, AlloVir, Asklepios Bio, Morphic, Gritstone and more

...Inc. Dynamk Capital Polyneuron Pharmaceuticals AG Vor Biopharma Inc. Prime Therapeutics LLC Oncoceutics Inc. Exicure Inc. ObsEva S.A. Acacia Pharma Group plc BioSpecifics Technologies Corp. Bolt Biotherapeutics Inc. Notable...
BioCentury | Sep 4, 2019
Company News

Management tracks: PhRMA, Arcus, Beam, Stealth, Bolt, Athenex, Click, Melinta, Kallyope and Genor

...hired Robert Weiskopf as CFO. Weiskopf was CFO of ArQule Inc. (NASDAQ:ARQL). Antibody conjugate company Bolt Biotherapeutics Inc....
...HillHouse Capital affiliated fund. Hongjiang Li, Staff Writer and Mary Romeo, Assistant Editor Arcus Biosciences Inc. Athenex Inc. Beam Therapeutics Bolt Biotherapeutics Inc. Click...
BioCentury | Aug 16, 2019
Finance

Chinese investment in U.S. biotechs to slow further

...biotechs. In February, the firm led the $54 million series B round for immuno-oncology company Bolt Biotherapeutics Inc....
...2020. Companies and Institutions Mentioned Ascletis Pharma Inc. (HKSE:1672), Hangzhou, China BioNTech SE, Mainz, Germany Bolt Biotherapeutics Inc....
BioCentury | Apr 5, 2019
Clinical News

Bolt's immune-stimulating antibody conjugates decrease tumor growth

...models. In a presentation at the American Association for Cancer Research (AACR) meeting in Atlanta, Bolt Biotherapeutics Inc....
...Toll-like receptor 7; TLR8 - Toll-like receptor 8 Mary Romeo, Staff Writer American Association for Cancer Research Bolt Biotherapeutics Inc. Toll-like...
BioCentury | Feb 8, 2019
Financial News

Bolt raises $54M series B

...Autoimmune company Bolt Biotherapeutics Inc. (Redwood City, Calif.) raised $54 million in a series B round led by...
...to convert cold tumors into immunologically hot tumors following systemic administration. Bolt Biotherapeutics Inc., Redwood City, Calif. Shannon Lehnbeuter Bolt Biotherapeutics Inc....
Items per page:
1 - 9 of 9